These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2414659)
21. A special lipid mixture for membrane fluidization. Lyte M; Shinitzky M Biochim Biophys Acta; 1985 Jan; 812(1):133-8. PubMed ID: 3838139 [TBL] [Abstract][Full Text] [Related]
22. AIDS drug shows promise in preliminary clinical trial. Marx JL Science; 1986 Mar; 231(4745):1504-5. PubMed ID: 3006242 [No Abstract] [Full Text] [Related]
23. Anti-AIDS agents show varying early results in vitro and in vivo. Riesenberg DE; Marwick C JAMA; 1985 Nov; 254(18):2521, 2527, 2529. PubMed ID: 2997490 [No Abstract] [Full Text] [Related]
24. [AIDS: the myth of Sisyphus]. Jaubert D Med Trop (Mars); 1999; 59(1):31-2. PubMed ID: 10472577 [No Abstract] [Full Text] [Related]
25. [The treatment of HIV infection in 1988: an update]. Chave JP Rev Med Suisse Romande; 1988 Aug; 108(8):691-6. PubMed ID: 2460908 [No Abstract] [Full Text] [Related]
26. Therapy other than reverse transcriptase inhibitors for HIV infection. Kaplan JC; Hirsch MS Clin Lab Med; 1994 Jun; 14(2):367-91. PubMed ID: 7523020 [TBL] [Abstract][Full Text] [Related]
27. Optimization of 5-aryloxyimidazole non-nucleoside reverse transcriptase inhibitors. Jones LH; Allan G; Corbau R; Hay D; Middleton DS; Mowbray CE; Newman SD; Perros M; Randall A; Vuong H; Webster R; Westby M; Williams D ChemMedChem; 2008 Nov; 3(11):1756-62. PubMed ID: 18855969 [TBL] [Abstract][Full Text] [Related]
29. Reduction of circulating HIV antigens in seropositive patients after treatment with AL-721. Yust I; Vardinon N; Skornick Y; Zakuth V; Hasner A; Shinitzky M Isr J Med Sci; 1990 Jan; 26(1):20-6. PubMed ID: 2179157 [TBL] [Abstract][Full Text] [Related]
30. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development. de Clercq E Med Res Rev; 1996 Mar; 16(2):125-57. PubMed ID: 8656777 [No Abstract] [Full Text] [Related]
31. HTLV-III AIDS link. Bennett JA Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353 [TBL] [Abstract][Full Text] [Related]
32. Ineffectiveness of AL721 in HIV disease. Peters BS; Bennett JM; Jeffries DJ; Knox K; Kocsis A; Pinching AJ Lancet; 1990 Mar; 335(8688):545-6. PubMed ID: 1968558 [No Abstract] [Full Text] [Related]
33. Inhibition by doxorubicin of human immuno-deficiency virus (HIV) infection and replication in vitro. Nakashima H; Yamamoto N; Inouye Y; Nakamura S J Antibiot (Tokyo); 1987 Mar; 40(3):396-9. PubMed ID: 2437093 [No Abstract] [Full Text] [Related]
34. Antiretroviral therapy for infection due to human immunodeficiency virus in children. Pizzo PA; Wilfert C Pediatr AIDS HIV Infect; 1994 Oct; 5(5):273-95. PubMed ID: 11361369 [No Abstract] [Full Text] [Related]
35. [A new AIDS drug in evaluation]. Fortschr Med; 1993 Aug; 111(24):12. PubMed ID: 7691696 [No Abstract] [Full Text] [Related]
36. [HTLV-III infection. New routes of transmission?]. Rasokat H Z Hautkr; 1986 Apr; 61(8):509-10. PubMed ID: 3012894 [No Abstract] [Full Text] [Related]
37. Kaplan memorial lecture. The family of human lymphotropic retroviruses called HTLV: HTLV-I in adult T-cell leukemia (ATL), HTLV-II in hairy cell leukemias, and HTLV-III in AIDS. Gallo RC Princess Takamatsu Symp; 1984; 15():13-38. PubMed ID: 6100633 [TBL] [Abstract][Full Text] [Related]
38. New developments in antiretroviral drug therapy for human immunodeficiency virus infections. Johnson VA; Hirsch MS AIDS Clin Rev; 1990; ():235-72. PubMed ID: 1707295 [No Abstract] [Full Text] [Related]
39. Approaches to AIDS therapy. Klatzmann D; Montagnier L Nature; 1986 Jan 2-8; 319(6048):10-11. PubMed ID: 3001533 [No Abstract] [Full Text] [Related]
40. A pathogenic retrovirus (HTLV-III) linked to AIDS. Broder S; Gallo RC N Engl J Med; 1984 Nov; 311(20):1292-7. PubMed ID: 6208484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]